[HTML][HTML] Accomplishment of α-Chymotrypsin on Photodynamic Effect of Octa-Substituted Zn (II)-and Ga (III)-Phthalocyanines against Melanoma Cells
V Mantareva, D Braikova, N Vilhelmova-Ilieva… - Inorganics, 2024 - mdpi.com
Octa-methylpyridiloxy-substituted Zn (II)-and Ga (III)-phthalocyanines (ZnPc1 and GaPc1)
were studied on human pigmented melanoma (SH4) and keratinocyte (HaCaT) cell lines …
were studied on human pigmented melanoma (SH4) and keratinocyte (HaCaT) cell lines …
A Protease Activatable Interleukin-2 Fusion Protein Engenders Antitumor Immune Responses by Interferon Gamma-Dependent and Interferon Gamma-Independent …
K Norville, D Skrombolas, SL Ferry… - Journal of Interferon & …, 2022 - liebertpub.com
Cytokines are powerful mediators of immune responses and some, such as interleukin-2 (IL-
2), have achieved dramatic responses as cancer immunotherapies. Unfortunately, systemic …
2), have achieved dramatic responses as cancer immunotherapies. Unfortunately, systemic …
Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer
The incidental detection of pancreatic cysts, an opportunity for the early detection of
pancreatic cancer, is increasing, owing to an aging population and improvements in imaging …
pancreatic cancer, is increasing, owing to an aging population and improvements in imaging …
Lanthanide DO3A-complexes bearing peptide substrates: The effect of peptidic side chains on metal coordination and relaxivity
Two DO3A-type ligands conjugated to substrates of urokinase (L3) and caspase-3 (L4) via a
propyl-amide linker were synthesized and their lanthanide (III)(Ln3+) complexes studied. A …
propyl-amide linker were synthesized and their lanthanide (III)(Ln3+) complexes studied. A …
Interrogating the Impact of Protease Activity on Tumor Progression Using 3D Spheroid Models
SV Gibson, EP Carter, RP Grose - Proteases and Cancer: Methods and …, 2023 - Springer
Cancers have a complex relationship with the surrounding environment that regulates
everything from progression to response to treatment. Cell–cell and cell–matrix interactions …
everything from progression to response to treatment. Cell–cell and cell–matrix interactions …
[HTML][HTML] Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity
Safety and efficacy of cancer-targeting treatments can be improved by conditional activation
enabled by the distinct milieu of the tumour microenvironment. Proteases are intricately …
enabled by the distinct milieu of the tumour microenvironment. Proteases are intricately …
A high throughput blood-based assay for the early detection of pancreatic cancer
JL Montoya Mira, A Quentel, RK Patel, D Keith… - medRxiv, 2024 - medrxiv.org
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers due in part
to the cancer being diagnosed is at a late stage when effective treatment options are limited …
to the cancer being diagnosed is at a late stage when effective treatment options are limited …
[HTML][HTML] Proteomic Analysis of HepG2 Cells Reveals FAT10 and BAG2 Signaling Pathways Affected by a Protease Inhibitor from Tinospora cordifolia (Willd.) Hook. f …
BS Chougule, K Gaurav, M Kumar… - Turk J Pharm …, 2024 - turkjps.org
Objectives Dysregulation of proteolysis underlies diseases like cancer. Protease inhibitors
(PIs) regulate many biological functions and hence have potential anticancer properties …
(PIs) regulate many biological functions and hence have potential anticancer properties …
Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents
Colorectal carcinogenesis is a complex process, which is linked to dysregulation of human
secretory phospholipases A2 (hsPLA2-G-IIA, hsPLA2-GV, and hsPLA2-GX), proteases …
secretory phospholipases A2 (hsPLA2-G-IIA, hsPLA2-GV, and hsPLA2-GX), proteases …
Proteolytic system parameters in the brain of rats with hyperhomocysteinemia
T Synelnyk, N Raksha, O Kostiuk… - … Società Italiana di …, 2024 - pagepressjournals.org
Hyperhomocysteinemia (HHcy) is now being actively studied as a potential risk factor and/or
biomarker for numerous pathological conditions, including brain diseases. This study aimed …
biomarker for numerous pathological conditions, including brain diseases. This study aimed …